コンテンツへスキップ
Merck
  • Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.

Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2017-06-20)
Arik Dahan, Milica Markovic, Svetlana Epstein, Noa Cohen, Ellen M Zimmermann, Aaron Aponick, Shimon Ben-Shabat
要旨

The enzyme phospholipase A

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
DL-2-Aminocaprylic acid, 99%